Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for selective cytotoxic effect on tumor cells
Most Correlated Studies
- B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Psoriatic lesional/non-lesional skin of ustekinumab or etanercept-treated responders/non-responders
- Lung squamous cell carcinoma cells treated with PXD101 (belinostat)
- Foreskin fibroblast BJ cells tumorigenic or normal treated with vorinostat
Most Relevant Literature
- Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tu…
- Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dend…
- Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.
- CDK4/6 inhibition triggers anti-tumour immunity.
- Dendritic Cells Transfected with a DNA Construct Encoding Tumour-associated Antigen Epitopes Induce …
Most Relevant Clinical Trials
- A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
- Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melano…
- Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neurob…
- Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infil…
- Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
